Research & Publications
Access peer-reviewed articles and publications from our data experts and customers who are utilizing Inovalon data to change healthcare.
Filter
May 21, 2023
Presentation
Measuring the Value and Return on Investment of Health Insurers Providing Non-Medical Benefits to Support Social Determinants of Health and Other Social Risk Factors
Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2023 Annual Conference. Findings available upon request. Contact us for more information.
May 21, 2023
Presentation
Development of a Social Determinants of Health Insights Dashboard to Support Organizations in Advancing Health Equity
Accepted for presentation at Pharmaceutical Management Science Association (PMSA) 2023 Annual Conference. Findings available upon request. Contact us for more information.
May 13, 2023
Presentation
Impact of Availability and Distance to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinson’s Disease
Yan C, Silverstein A, Schinkel J, Teigland C, Strezewski J, Kukreja P, Shah M, Kandukuri K, Shewale A, Shahed JJ, Fernandez H
Accepted for presentation at International Association of Parkinsonism and Related Disorders (IAPRD), World Congress 2023. Findings available upon request. Contact us for more information.May 7, 2023
Presentation
Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinson’s Disease
Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.
May 7, 2023
Presentation
Characteristics, Healthcare Resource Utilization, Cost, and Quality Outcomes of Medicare Beneficiaries While Commercially Insured Before and After Transition to Medicare Advantage or Traditional Medicare Fee-for-Service
Accepted for presentation at ISPOR 2023. Findings available upon request. Contact us for more information.
May 3, 2023
Poster Presentation
Long COVID-19 Associated with 5-Fold Increase in Total Medical Costs and Greater Use of Inpatient and Outpatient Services Compared to Non-Long COVID-19: An Analysis of Real World Data.
This study assessed real-world evidence data on the prevalence and impact of long COVID (LC) to establish a baseline for the value of potential therapeutic interventions.
May 3, 2023
Poster Presentation
Treatment Patterns and Healthcare Resource Utilization in Patients with Relapsed/Refractory Multiple Myeloma (RRMM), Classified by Urbanicity and Ethnicity.
RRMM remains incurable making long-term clinical management complex. Furthermore, disparities in mortality, incidence and treatment utilization exist, with newer, more effective and expensive therapies underutilized. Better understanding of disparities in healthcare resource utilization (HCRU) and treatment patterns is necessary to improve outcomes for these patients.
May 3, 2023
Poster Presentation
An Assessment of the Direct and Indirect Costs of Bladder Cancer Preceding and Following a Cystectomy: A Real-World Evidence Study
This study estimated the direct and indirect costs of bladder cancer prior to and following cystectomy.
